BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 28618162)

  • 1. ZEB1-regulated inflammatory phenotype in breast cancer cells.
    Katsura A; Tamura Y; Hokari S; Harada M; Morikawa M; Sakurai T; Takahashi K; Mizutani A; Nishida J; Yokoyama Y; Morishita Y; Murakami T; Ehata S; Miyazono K; Koinuma D
    Mol Oncol; 2017 Sep; 11(9):1241-1262. PubMed ID: 28618162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
    Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
    Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SPRY4‑IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR‑101 activity.
    Yao H; Hou G; Wang QY; Xu WB; Zhao HQ; Xu YC
    Int J Oncol; 2020 Jan; 56(1):85-100. PubMed ID: 31746422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
    Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
    Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer.
    Hou P; Li L; Chen F; Chen Y; Liu H; Li J; Bai J; Zheng J
    Cancer Res; 2018 Jan; 78(2):387-398. PubMed ID: 29187406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
    Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
    Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression.
    Hou LK; Yu Y; Xie YG; Wang J; Mao JF; Zhang B; Wang X; Cao XC
    Oncotarget; 2016 May; 7(18):26016-26. PubMed ID: 27036021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
    Zhou X; Men X; Zhao R; Han J; Fan Z; Wang Y; Lv Y; Zuo J; Zhao L; Sang M; Liu XD; Shan B
    Cancer Gene Ther; 2018 May; 25(3-4):68-76. PubMed ID: 29302045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8
    Guan T; Dominguez CX; Amezquita RA; Laidlaw BJ; Cheng J; Henao-Mejia J; Williams A; Flavell RA; Lu J; Kaech SM
    J Exp Med; 2018 Apr; 215(4):1153-1168. PubMed ID: 29449309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFAP2A is a component of the ZEB1/2 network that regulates TGFB1-induced epithelial to mesenchymal transition.
    Dimitrova Y; Gruber AJ; Mittal N; Ghosh S; Dimitriades B; Mathow D; Grandy WA; Christofori G; Zavolan M
    Biol Direct; 2017 Apr; 12(1):8. PubMed ID: 28412966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells.
    Xavier PLP; Cordeiro YG; Rochetti AL; Sangalli JR; Zuccari DAPC; Silveira JC; Bressan FF; Fukumasu H
    Vet Comp Oncol; 2018 Dec; 16(4):596-605. PubMed ID: 30047225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.
    Wang J; Farkas C; Benyoucef A; Carmichael C; Haigh K; Wong N; Huylebroeck D; Stemmler MP; Brabletz S; Brabletz T; Nefzger CM; Goossens S; Berx G; Polo JM; Haigh JJ
    PLoS Biol; 2021 Sep; 19(9):e3001394. PubMed ID: 34550965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumoral and stromal expression of Slug, ZEB1, and ZEB2 in brain metastasis.
    Nagaishi M; Nakata S; Ono Y; Hirata K; Tanaka Y; Suzuki K; Yokoo H; Hyodo A
    J Clin Neurosci; 2017 Dec; 46():124-128. PubMed ID: 28890036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101.
    Cheng Y; Chang Q; Zheng B; Xu J; Li H; Wang R
    Eur J Pharmacol; 2019 Jan; 843():210-216. PubMed ID: 30472203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.
    Chen P; Liu H; Hou A; Sun X; Li B; Niu J; Hu L
    Med Sci Monit; 2018 Feb; 24():1145-1151. PubMed ID: 29476046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.
    Zhao L; Li R; Xu S; Li Y; Zhao P; Dong W; Liu Z; Zhao Q; Tan B
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):171-180. PubMed ID: 29329360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 2 induces proliferation and fibrosis via SNAI1-mediated activation of CDK2 and ZEB1 in corneal endothelium.
    Lee JG; Jung E; Heur M
    J Biol Chem; 2018 Mar; 293(10):3758-3769. PubMed ID: 29363574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty Acids and a High-Fat Diet Induce Epithelial-Mesenchymal Transition by Activating TGFβ and β-Catenin in Liver Cells.
    Kwapisz O; Górka J; Korlatowicz A; Kotlinowski J; Waligórska A; Marona P; Pydyn N; Dobrucki JW; Jura J; Miekus K
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.